Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.
Eur Heart J Cardiovasc Pharmacother
; 8(8): 786-795, 2022 12 02.
Article
in En
| MEDLINE
| ID: mdl-35383832
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stroke
/
Peripheral Arterial Disease
/
Myocardial Infarction
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Humans
/
Infant
Language:
En
Journal:
Eur Heart J Cardiovasc Pharmacother
Year:
2022
Type:
Article